The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Increased Susceptibility of Nrf2 Knockout Mice to Colitis-Associated Colorectal Cancer
Open accessPublished version of a preprint
Abstract
The nuclear factor-erythroid 2-related factor 2 (Nrf2) plays a critical role in protecting various tissues against inflammation, which is a potential risk factor for colorectal and other cancers. Our previously published mouse model work showed that Nrf2 helps protect against dextran sulfate sodium (DSS)-induced colitis/inflammation, and others have shown that Nrf2 helps protect against inflammation-associated colorectal carcinogenesis (aberrant crypt foci). The present study extended these important earlier findings by exploring the role of Nrf2 in colitis-associated colorectal cancer in a mouse model involving azoxymethane/DSS-induced colorectal carcinogenesis in Nrf2 knockout mice. Azoxymethane/DSS-treated Nrf2 knockout mice had increased incidence, multiplicity, and size of all colorectal tumors, including adenomas, versus treated wild-type (WT) mice, and the proportion of tumors that were adenocarcinoma was much higher in knockout (80%) versus WT (29%) mice. Compared with WT mice, knockout mice also had increased markers of inflammation in tumor tissue (cyclooxygenase-2 and 5-lipoxygenase expressions and prostaglandin E(2) and leukotriene B(4) levels) and in inflamed colonic mucosa (nitrotyrosine expression), supporting the association of knockout mouse tumor formation with inflammation. The phase II detoxifying/antioxidant enzymes NAD(P)H-quinone reductase 1 and UDP-glucurosyltransferase 1A1 were elevated in the normal mucosa of WT, but not Nrf 2 knockout, mice treated with azoxymethane/DSS. Our findings show that Nrf2 plays a critical role in protecting against inflammation-associated colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our data show that tissue and plasma from Nrf2KO mice present higher levels of inflammation at 4 month of age (measured by the cytokine levels), corroborating previous reports (Ishii et al., 2005; Khor et al., 2008).”
From Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism (2017) · cites this paper as Khor et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,948
Christakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,290
Ulcerative Colitis and Colorectal Cancer
Ekbom, A., Helmick, C. G., Zack, M. M., & Adami, H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231802 · Cited by 1,794
Itzkowitz, S. H., & Yio, X. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00079.2004 · Cited by 1,272
Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis
Thimmulappa, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25790 · Cited by 1,028 · cited 2×
“Our present study joins other recent studies (6, 15, 16), including our study showing that Nrf2deficient mice were more susceptible to DSS-induced colitis (6), in suggesting that Nrf2 may play a central role in regulating inflammation because Nrf2 is an integral regulator of detoxification and antioxidation mechanisms.”
BackgroundResultGenetic ablation of Nrf2 enhances susceptibility to cigarette smoke–induced emphysema in mice
Rangasamy, T., Cho, C. Y., Thimmulappa, R. K., Zhen, L., Srisuma, S., Kensler, T. W., Yamamoto, M. P., Petrache, I., Tuder, R. M., & Biswal, S. S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21146 · Cited by 993
Prostaglandins, Arachidonic Acid, and Inflammation
Kuehl, F. A., & Egan, R. W. (1980) · Science · doi:10.1126/science.6254151 · Cited by 710
Nrf2-Deficient Mice Have an Increased Susceptibility to Dextran Sulfate Sodium–Induced Colitis
Khor, T. O., Huang, M., Kwon, K. H., Chan, J. Y., Reddy, B. S., & Kong, A. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3562 · Cited by 530
Self-citationUlcerative colitis and colorectal cancer
Ekbom, A. (1991) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(91)90009-i · Cited by 419
Xu, C., Huang, M., Shen, G., Yuan, X., Lin, W., Khor, T. O., Conney, A. H., & Kong, A. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0300 · Cited by 379
Self-citation
Cited by
Sorted by citations
Items 201–300 of 307
Autophagy mediates epithelial cancer chemoresistance by reducing p62/SQSTM1 accumulation
Battista, R. A., Resnati, M., Facchi, C., Ruggieri, E., Cremasco, F., Paradiso, F., Orfanelli, U., Giordano, L., Bussi, M., Cenci, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201621 · Cited by 23
Role of NRF2 in Colorectal Cancer Prevention and Treatment
Li, J., Wang, D., Liu, Y., & Zhou, Y. (2022) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221105736 · Cited by 24
Self-citationBousquet, M. S., Ratnayake, R., Pope, J. L., Chen, Q.-Y., Zhu, F., Chen, S., Carney, T. J., Gharaibeh, R. Z., Jobin, C., Paul, V. J., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.013 · Cited by 23
Nrf2 Is Involved in Maintaining Hepatocyte Identity during Liver Regeneration
Zou, Y., Lee, J., Nambiar, S. M., Hu, M., Rui, W., Bao, Q., Chan, J. Y., & Dai, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107423 · Cited by 21
Self-citationThanan, R., Ma, N., Iijima, K., Abe, Y., Koike, T., Shimosegawa, T., Pinlaor, S., Hiraku, Y., Oikawa, S., Murata, M., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.152 · Cited by 22
Townsend, B. E., & Johnson, R. W. (2015) · Nutritional Neuroscience · doi:10.1080/1028415x.2015.1103463 · Cited by 21
Targeting Transcription Factors for Cancer Prevention—the Case of Nrf2
Colburn, N. H., & Kensler, T. W. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0025 · Cited by 21
Sexual dimorphism in colorectal cancer: molecular mechanisms and treatment strategies
Rodríguez-Santiago, Y., Garay-Canales, C. A., Castro, K. E. N., & Morales‐Montor, J. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00623-1 · Cited by 25
Role of Nrf2, STAT3, and Src as Molecular Targets for Cancer Chemoprevention
Ahsan, H., Islam, S. U., Ahmed, M. B., & Lee, Y. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091775 · Cited by 20
Jiang, Y., Ni, S., Xiao, B., & Jia, L. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.019 · Cited by 22
Chen, Y., Zheng, Z.-H., Li, C., Pan, Y., Tang, X., & Wang, X. J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7180284 · Cited by 20
Organomagnesium suppresses inflammation-associated colon carcinogenesis in male Crj: CD-1 mice
Kuno, T., Hatano, Y., Tomita, H., Hara, A., Hirose, Y., Hirata, A., Mori, H., Terasaki, M., Masuda, S., & Tanaka, T. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs348 · Cited by 19
Diabetic Wound Healing and Activation of Nrf2 by Herbal Medicine.
Senger, D. R., & Cao, S. (2016) · PubMed · Cited by 19
Pietrofesa, R. A., Chatterjee, S., Park, K., Arguiri, E., Albelda, S. Μ., & Christofidou‐Solomidou, M. (2018) · Antioxidants · doi:10.3390/antiox7030038 · Cited by 19
Inhibition of Nrf2 promotes the antitumor effect of Pinelliae rhizome in papillary thyroid cancer
Du, Z., Wang, Q., Ma, G., Jiao, J., Jiang, D., Zheng, X., Qiu, M., & Liu, S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28069 · Cited by 19
Yao, J., Liu, J., Kong, X.-Z., Zhang, S., Wang, X.-H., Yu, M., Zhan, Y., Li, W., Xu, W., Tang, L., et al. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.12.027 · Cited by 19
Nrf2 is not required for epithelial prohibitin-dependent attenuation of experimental colitis
Kathiria, A. S., Butcher, M. A., Hansen, J. M., & Theiss, A. L. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00327.2012 · Cited by 18
Gao, L., Yuan, F., Che, G., Xiao, X., Nie, X., Wang, Y., Jia, J., Kong, A. T., & Zhang, L. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28495 · Cited by 18
Self-citationKang, C., Song, C., Kim, N., Nam, R. H., Choi, S. I., Yu, J. E., Nho, H., Choi, J. A., Kim, J. W., Na, H. Y., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.679324 · Cited by 17
ROS release by PPARβ/δ-null fibroblasts reduces tumor load through epithelial antioxidant response
Tan, E. H. P., Sng, M. K., How, I. S. B., Chan, J. S. K., Chen, J., Tan, C. K., Wahli, W., & Tan, N. S. (2018) · Oncogene · doi:10.1038/s41388-017-0109-8 · Cited by 17
Self-citationNrf2 as a Molecular Guardian of Redox Balance and Barrier Integrity in IBD
Stojanović, B., Bevc, I. M., Stojanovic, M. D., Stojanović, B., Jovanović, M., Lazarevic, S. R., Milošević, B., Radosavljević, I., Tasić-Uroš, D., Marković, N., et al. (2025) · Antioxidants · doi:10.3390/antiox14121407 · Cited by 20
Wang, K., Zhang, C., Zhang, S., Liu, E.-D., Dong, L., Kong, X.-Z., Cao, P., Hu, C., Zhao, K., Zhan, Y., et al. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/959253 · Cited by 16
Hepatocellular iNOS protects liver from NASH through Nrf2-dependent activation of HO-1
Qiao, Y., Li, X., Zhang, X., Xiao, F., Zhu, Y., Fang, Z., & Sun, J. L. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.04.144 · Cited by 16
Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases
Carlson, J., Price, L., & Deng, H. (2020) · Progress in inflammation research · doi:10.1007/978-3-030-44599-7_3 · Cited by 17
Wang, L., Wu, R., Sargsyan, D., Su, S., Kuo, H. D., Li, S. N., Chou, P. J., Sarwar, M. S., Phadnis, A., Wang, Y., et al. (2022) · The AAPS Journal · doi:10.1208/s12248-022-00679-0 · Cited by 16
Self-citationNRF2 as a ferroptosis gatekeeper in colorectal cancer: implications for therapy
El‐Sehrawy, A. A. M. A., Al-dulaimi, A. A., Alkhathami, A. G., RenukaJyothi, S., Panigrahi, R., Pargaien, A. V., Singh, U., Husseini, A., & Alnajar, M. J. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04324-3 · Cited by 16
Ong, A. J. S., Saeidi, S., Kieu, N. H., Kim, S. J., Kim, D., Kim, S. H., Park, S., Cha, Y., Na, H., & Surh, Y. (2020) · Free Radical Research · doi:10.1080/10715762.2020.1761547 · Cited by 15
Bak, M., Jess, T., Flachs, E. M., Zwisler, A., Juel, K., & Frederiksen, H. (2020) · Cancers · doi:10.3390/cancers12092700 · Cited by 16
Emerging perspectives of copper-mediated transcriptional regulation in mammalian cell development
Fitisemanu, F. M., & Padilla‐Benavides, T. (2024) · Metallomics · doi:10.1093/mtomcs/mfae046 · Cited by 14
Yin, Q., Zhu, L., Liu, D., Irwin, D. M., Zhang, S. Y., & Pan, Y.-H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146274 · Cited by 13
Ohshiro, K., Chen, J., Srivastav, J., Mishra, L., & Mishra, B. (2020) · Genes & Cancer · doi:10.18632/genesandcancer.199 · Cited by 14
Cellular Nrf2 Levels Determine Cell Fate during Chemical Carcinogenesis in Esophageal Epithelium
Horiuchi, M., Taguchi, K., Hirose, W., Tsuchida, K., Suzuki, M., Taniyama, Y., Kamei, T., & Yamamoto, M. P. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00536-20 · Cited by 12
Protective Effect of Dioscorea batatas Peel Extract Against Intestinal Inflammation
Lim, J. S., Oh, J., Byeon, S., Lee, J. S., & Kim, J. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2018.4187 · Cited by 12
Miyamoto, S., Narita, T., Komiya, M., Fujii, G., Hamoya, T., Nakanishi, R., Tamura, S., Kurokawa, Y., Takahashi, M., & Mutoh, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-42363-y · Cited by 12
Exploring structural effects in a new class of NRF2 inhibitors
Hou, Z., Lockwood, L. R., Zhang, D., Occhiuto, C. J., Mo, L., Aldrich, K. E., Stoub, H., Gallo, K. A., Liby, K. T., & Odom, A. L. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00211f · Cited by 11
Fousekis, F. S., Mpakogiannis, K. C., Filis, P., Skamnelos, A., Christodoulou, D. K., Mauri, D., & Katsanos, K. H. (2025) · Cancers · doi:10.3390/cancers17020229 · Cited by 12
Achy-Brou, C. A. A., & Billack, B. (2016) · Drug and Chemical Toxicology · doi:10.3109/01480545.2016.1169542 · Cited by 11
Choo, J., Heo, G., Kim, S. J., Lee, Y., Ishigami, A., Maruyama, N., Chung, H. Y., & Im, E. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.031 · Cited by 11
Autophagy and Apoptosis in Inflammatory Bowel Disease
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2023) · Gastroenterology Insights · doi:10.3390/gastroent14040042 · Cited by 10
Li, K., Chen, Z., Wang, B., He, J., & Bi, J. (2013) · Journal of Molecular Histology · doi:10.1007/s10735-013-9538-z · Cited by 10
Mechanisms of protective effects of astaxanthin in nonalcoholic fatty liver disease
Gao, L.-J., Zhu, Y., & Xu, L. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2020.150 · Cited by 10
How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy
Tang, Y.-C., Chuang, Y., Chang, H.-H., Juang, S., Yen, G., Chang, J.-Y., & Kuo, C. (2023) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.3463 · Cited by 11
Gu, L., Li, H., Gao, L., Li, H., Wei, L.-F., Pan, C.-Y., Wu, K., & Tian, Y. (2023) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-023-3554-y · Cited by 9
Ateş, İ., Yılmaz, A. D., Buttari, B., Arese, M., Saso, L., & Süzen, S. (2023) · Brain Sciences · doi:10.3390/brainsci13111532 · Cited by 9
Li, Y., Li, H. Z., Cui, M., Zhou, Y., Zhang, M., & Zhang, M. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2908276 · Cited by 8
Chen, J., Su, S., Pickar‐Oliver, A., Chiarella, A. M., Hahn, Q., Goldfarb, D., Cloer, E. W., Small, G. W., Sivashankar, S., Ramsden, D. A., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae761 · Cited by 8
Polimeno, L., Viggiani, M. T., Giorgio, F., Polimeno, L., Fratantonio, D., Domenico, M. D., Boccellino, M., Ballini, A., Topi, S., Leo, A. D., et al. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.01.131 · Cited by 8
Trio, P. Z., Kawahara, A., Tanigawa, S., Sakao, K., & Hou, D. (2016) · Nutrition and Cancer · doi:10.1080/01635581.2017.1248296 · Cited by 8
Nrf2 in Immune Responses During Inflammation
Hohmann, M. S., Zaninelli, T. H., Staurengo‐Ferrari, L., Manchope, M. F., Badaro‐Garcia, S., de Freitas, A., Casagrande, R., & Verri, W. A., Jr. (2020) · Progress in inflammation research · doi:10.1007/978-3-030-44599-7_2 · Cited by 7
Possible involvement of granulocyte oxidative burst in Nrf2 signaling in cancer.
Jaganjac, M. (2010) · PubMed · Cited by 7
Lee, J., Zhong, X., Lee, J.-Y., Surh, Y., & Na, H. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108162 · Cited by 7
Ajuwon, O. R., Biteghe, F. A. N., Ndong, J. D. L. C., Davids, L. M., Ajiboye, B. O., Brai, B. I. C., Bamisaye, F. A., Falode, J. A., Odoh, I. M., Adegbite, K., et al. (2024) · OncoTargets and Therapy · doi:10.2147/ott.s457749 · Cited by 9
Unlocking the potential of methionine: a dietary supplement for preventing colitis
Wang, H., He, Y., Wang, S.-W.-M., Rahman, M. A. U., Zhang, S., Shi, C., Wang, H.-M., & Su, H.-W. (2024) · Food & Function · doi:10.1039/d4fo02883j · Cited by 6
Östreicher, C., Bartenbacher, S., & Pischetsrieder, M. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.06.023 · Cited by 6
Supplementation with High or Low Iron Reduces Colitis Severity in an AOM/DSS Mouse Model
Moon, S., Kim, M., Kim, Y.-H., & Lee, S.-M. (2022) · Nutrients · doi:10.3390/nu14102033 · Cited by 6
Hua, W., Li, M., Yan, Z., Wang, Y., Zhou, X., Fu, Z., Wáng, Y., Zhang, S., & Qian, J. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01966-w · Cited by 7
Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma
Peng, X., Feng, J., Yang, H., Xia, P., & Pu, F. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101335 · Cited by 6
Thyroglobulin as a negative marker for malignancy in canine and human breast tumors
Hwang, S., Yang, Y., Woo, S., Jung, J., Seo, D., Kim, D.-Y., & Kim, Y. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23304 · Cited by 5
Wu, X., Chen, X.-M., Zhou, M., Hu, H., Zhang, J., Wang, X., Ren, D., Lou, H., & Shen, T. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108741 · Cited by 5
Zhan, M., Qin, Y., Yu, L., Li, Q., Jiang, M., Wu, D., Jian, M., Cao, H., & Bin, D. (2025) · Phytotherapy Research · doi:10.1002/ptr.70065 · Cited by 4
Cancer chemopreventive natural products
Ritchie, K. J., & Sarker, S. D. (2020) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.02.004 · Cited by 4
Tungalag, T., Park, J. Y., Park, K. W., & Yang, D. K. (2023) · Food Science and Biotechnology · doi:10.1007/s10068-023-01367-1 · Cited by 4
Neufeld, K. L., & Zeineldin, M. (2015) · Gastrointestinal Cancer Targets and Therapy · doi:10.2147/gictt.s51386 · Cited by 5
Molecular Mechanisms of Nrf2 in Inflammation: Interactions Between Nrf2 and Inflammatory Mediators
Wang, R., & Pérez, V. (2020) · Progress in inflammation research · doi:10.1007/978-3-030-44599-7_1 · Cited by 3
Nrf2 as a Possible Determinant of the Threshold for Carcinogenesis
Aoki, Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801663-3.00010-8 · Cited by 3
Molecular mechanisms of intestinal inflammation leading to colorectal cancer
Shastri, S., Vemuri, R., Gueven, N., Shastri, M. D., & Eri, R. D. (2017) · AIMS Biophysics · doi:10.3934/biophy.2017.1.152 · Cited by 3
The Role of Oxidative Stress in the Pathophysiology of Gastrointestinal Disorders
Mosińska, P., Sałaga, M., & Fichna, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805377-5.00004-7 · Cited by 3
Adopting Nrf2 and NF-κB from cancer: Is there any role of the duo in diabetes?Preprint
Negi, G., Kumar, A., & Sharma, S. S. (2011) · Nature Precedings · doi:10.1038/npre.2011.6581.1 · Cited by 3
Hu, H., Zheng, K., Xu, X., Li, B., Yin, Q., Zeng, H., Jiang, Y., Zhang, Z., Ma, S., Chen, T., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3462559/v1 · Cited by 3
The Anticarcinogenic Properties of Brassica Vegetables
Ross, I. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-63681-3_5 · Cited by 2
Mechanistic role of Nrf2 modulators in lipid peroxidation: a perspective towards carcinogenesis
Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001372 · Cited by 2
A New Theory of Chemically Induced Tumorigenesis
Bogen, K. T. (2016) · Advances in molecular toxicology · doi:10.1016/b978-0-12-804700-2.00001-5 · Cited by 2
Feed-Forward and Feed-Back Circuits of the NRF2/AP-1 Composite Pathway
Zolotukhin, P. V., & Belanova, A. A. (2016) · InTech eBooks · doi:10.5772/65216 · Cited by 2
Mao, X. (2019) · Springer eBooks · doi:10.1007/978-3-030-26780-3_16 · Cited by 2
Survival Strategy and Disease Pathogenesis According to the Nrf2‐Small Maf Heterodimer
Morita, M., & Motohashi, H. (2011) · doi:10.1002/9781118148143.ch5 · Cited by 2
Role of Focal Adhesion Kinase and NRF2 Pathways in Gastrointestinal Wound Healing
Cleveland, O. G., & Vomhof‐DeKrey, E. E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146335 · Cited by 1
Emerging epigenetics in cancer chemoprevention by dietary phytochemicals
Zhang, C. (2017) · doi:10.7282/t3n01903 · Cited by 1
Haller, F., Jimenez, K., Baumgartner, M., Lang, M., Klotz, A., Jambrich, M., Busslinger, G. A., Müllauer, L., Khare, V., & Gasché, C. (2024) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-23-0478 · Cited by 1
Barker, E. C. (2015) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Some Aspects of Oxidative Stress–Induced Prostate Cancer Therapy
Alam, M. N., Chakraborti, T., Ghosh, P., Pramanik, P. K., Devgupta, P., & Chakraborti, S. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_144 · Cited by 1
Physiopathology of Hepatocellular Carcinoma
Nault, J., & Zucman‐Rossi, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.04213-1 · Cited by 1
Targeting Nrf2 in inflammation and cancer
Cowan, J. (2014) · UEA Digital Repository (University of East Anglia) · Cited by 1
Reversing Breast Cancer-Induced Immune Suppression
Beury, D. W., & Ostrand‐Rosenberg, S. (2013) · doi:10.21236/ada573503
Cancer Chemopreventive Phytochemicals Targeting NF‐κB and Nrf2 Signaling Pathways
Na, H., & Surh, Y. (2015) · doi:10.1002/9781118930458.ch9
Role of BTG2 in the antioxidant response in human breast epithelial cells
Karve, T. M. (2012) · DigitalGeorgetown (Georgetown University Library)
Villeneuve, N. (2011) · UA Campus Repository (The University of Arizona)
Inflammation and Lung Cancer: Prevention
Bauer, A. K., Miller, Y. E., & Keith, R. L. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2724-1_4
Molecular Mechanisms of Phytochemical Actions in Cancer
Roy, M., & Datta, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-9471-3_5
Increasing Chemosensitivity in Colorectal Cancer
Agro, L. A. (2019) · TSpace (University of Toronto)
Rehman, M. U., Rashid, S., Arafah, A. M., Qamar, W., Alsaffar, R. M., Ahmad, A., Almatroudi, N. M., Alqahtani, S. M. A., Rashid, S. M., & Ahmad, S. B. (2020) · doi:10.21203/rs.3.rs-38948/v1
LiChen, K., & Wang, Z. (2014)
Some Aspects of Oxidative Stress–Induced Prostate Cancer Therapy
Alam, M. N., Chakraborti, T., Ghosh, P., Pramanik, P. K., Devgupta, P., & Chakraborti, S. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_144-1
祖丽皮耶, ·. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13102289
Activating NRF2E79Q mutation alters the differentiation of human non-small cell lung cancer
Hamad, S. H., Joshi, H., Hess, T., Jefferys, S. R., Saleh, Z., Bendjilali, N., Sellers, R. S., Zhu, G. G., Schrank, T. P., Moore, R., et al. (2025) · Cancer Gene Therapy · doi:10.1038/s41417-025-00966-w
Pal, S., Panda, A., Bhowmick, B., & Bera, K. (2025) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2025.100714
Zhang, Y., Lei, H., Wang, P., Zhou, Q., Yu, J., Leng, X., Ma, R., Wang, D., Dong, K., Xing, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23803085
Rôle de la pantéthéinase épithéliale Vanin-1 dans l'inflammation intestinale
Gensollen, T. (2014) · theses.fr (ABES) · doi:10.70675/4525dc6dz222cz40b2za3b8z6077ea8bed51
Metadata
- Authors
- Khor, T. O., Huang, M.-T., Prawan, A., Liu, Y., Hao, X., Yu, S., Cheung, W. K. L., Chan, J. Y., Reddy, B. S., Yang, C. S., & Kong, A.-N.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Kong, Ah-Ng
- Venue
- Cancer Prevention Research
- Published
- 2008-07-25
- Volume
- 1
- Issue
- 3
- Pages
- 187-191
- ISSN
- 1940-6207 (ISSN-L)
- 1940-6215
- PMC
- PMC3580177
- OpenAlex
- W2141004419
- Cited by
- 306
- References
- 22
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 9 · 2023: 17 · 2022: 18 · 2021: 10 · 2020: 23 · 2019: 28 · 2018: 21 · 2017: 34 · 2016: 22 · 2015: 22 · 2014: 18 · 2013: 16 · 2012: 16
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Prevention Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA073674)
- National Institute of Environmental Health Sciences (P30ES005022)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- Nrf2, colitis-associated colorectal cancer, Nrf2 knockout mice, inflammation-associated carcinogenesis, colorectal adenoma, cyclooxygenase-2, 5-lipoxygenase, prostaglandin E2, leukotriene B4, nitrotyrosine, UDP-glucuronosyltransferase 1A1, phase II enzymes, antioxidant defense
- MeSH terms
- Adenocarcinoma, Adenoma, Animals, Azoxymethane, Colitis, Male, Mice, Inbred C57BL, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Dextran Sulfate, Mice, Knockout, Cytoprotection, Genetic Predisposition to Disease, NF-E2-Related Factor 2, Mice, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
